Standard Biotools (LAB) Gains from Sales and Divestitures (2023 - 2025)
Standard Biotools (LAB) reported Gains from Sales and Divestitures of $8.2 million for Q4 2025, up 2051.96% year-over-year from $383000.0 in Q4 2024, and up 2051.96% on a QoQ basis from $383000.0 in Q4 2024.
Standard Biotools (LAB) has 3 years of Gains from Sales and Divestitures data on file, last reported at $8.2 million in Q4 2025.
- Quarterly Gains from Sales and Divestitures rose 2051.96% year-over-year to $8.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.2 million (up 2051.96% YoY) and the FY2025 annual result came in at $8.2 million, up 2051.96% from the prior year.
- Gains from Sales and Divestitures rose to $8.2 million in Q4 2025 per LAB's latest filing, from $383000.0 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $8.2 million in Q4 2025 and bottomed at $52000.0 in Q3 2023.
- The 3-year median for Gains from Sales and Divestitures is $383000.0 (2024), against an average of $2.1 million.
- Peak annual rise in Gains from Sales and Divestitures reached 7596.15% in 2024, while the deepest fall reached 636.54% in 2024.
- Tracing LAB's Gains from Sales and Divestitures over 3 years: stood at $52000.0 in 2023, then surged by 636.54% to $383000.0 in 2024, then surged by 2051.96% to $8.2 million in 2025.
- Per Business Quant, the three latest LAB Gains from Sales and Divestitures figures stand at $8.2 million (Q4 2025), $383000.0 (Q4 2024), and $4.0 million (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.24 Mn |
| Dec 31, 2025 | 8.24 Mn |
| Dec 31, 2024 | 383,000.00 |
| Dec 31, 2024 | 383,000.00 |
| Sep 30, 2024 | 4.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 283,000.00 |
| Jun 30, 2024 | 283,000.00 |
| Mar 31, 2024 | 1.74 Mn |
| Mar 31, 2024 | 1.74 Mn |
| Dec 31, 2023 | 52,000.00 |
| Dec 31, 2023 | 52,000.00 |
| Sep 30, 2023 | 52,000.00 |
| Sep 30, 2023 | 52,000.00 |